Showing all 10 results
Adefovir Dipivoxil Tablets
FreeProduct Composition & Strengths
We supply this therapeutic in the globally accepted standard therapeutic strength optimized for adult daily maintenance therapy.
Active Ingredient Standard Strength Primary Clinical Target Adefovir Dipivoxil IP / BP / USP 10 mg The Polymerase Blocker: Daily oral dose to suppress chronic Hepatitis B viral loads. Excipients Pharma Grade The Matrix: High-stability lactose/microcrystalline cellulose binders. Chlorpromazine Tablets
FreeProduct Composition & Available Strengths
We provide this therapeutic in a versatile range of strengths to allow for the precise dose titration required in specialized psychiatric medicine.
Active Ingredient Standard Strengths Primary Clinical Target Chlorpromazine HCl IP/BP/USP 25 mg Low-Dose Titration: For anxiety, pediatric hiccups, or elderly care. Chlorpromazine HCl IP/BP/USP 50 mg Maintenance Therapy: For stable outpatient management of schizophrenia. Chlorpromazine HCl IP/BP/USP 100 mg Acute Crisis Control: High-potency dosing for acute manic or psychotic states. Cinnarizine Tablets
FreeTechnical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
Technical Metric Specification Standard Active Ingredient Cinnarizine BP / USP / IP Dosage Form Immediate Release Tablets Available Strengths 25 mg (Vestibular) / 75 mg (Cerebrovascular) HS Code 3004.90.39 (Other CNS drugs) / 2933.59.90 Stability Validated for Zone IVb (Tropical) export markets Clozapine Tablets
FreeProduct Composition & Available Titration Strengths
Because Clozapine demands highly delicate, low-dose initial titration to protect the patient’s cardiovascular profile, we manufacture the full compendial strength spectrum.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clozapine USP / BP / IP 25 mg Oral Solid Uncoated Micro-Tablet Introductory Safety Titration: Mandatory low-dose baseline format utilized exclusively for the initial day 1 and day 2 dose-escalation phase to prevent orthostatic shock. Clozapine USP / BP / IP 50 mg Oral Solid Uncoated Micro-Tablet Intermediate Dose Step-Up: Mid-tier titration strength engineered to scale up systemic tolerance during weeks 1 and 2. Clozapine USP / BP / IP 100 mg Oral Solid Compressed Tablet The Core Commercial Volume: First-line international standard target maintenance strength for adult refractory schizophrenia management. Methylprednisolone Tablet
FreeProduct Composition & Available Strengths
We supply Methylprednisolone in a comprehensive, internationally standardized range of strengths to facilitate both low-dose chronic maintenance and the high-dose taper packs mandatory in clinical steroid therapy.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Methylprednisolone USP / BP / IP 4 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Baseline Dose / Tapering: For rheumatoid arthritis maintenance and step-down dose regimens. Methylprednisolone USP / BP / IP 8 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Intermediate Management: For moderate asthma exacerbations and chronic dermatological conditions. Methylprednisolone USP / BP / IP 16 mg Oral Solid Uncoated Tablet (Cross-scored for flexible division) High-Potency Control: For acute autoimmune flares, immunosuppression in organ transplants, and oncology support. Metoclopramide Tablet
FreeProduct Composition & Packaging Specification
We supply Metoclopramide in the globally standardized therapeutic strength optimized for adult baseline three-times-daily dosage regimens.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Function Metoclopramide Hydrochloride USP / BP / IP 10 mg Oral Solid Uncoated Tablet (Scored for micro-dosing titration) The Prokinetic Driver: Accelerates upper gastrointestinal transit and blocks central emetic signals. Excipients Pharma Grade Lactose, Starch, Magnesium Stearate The Core Scaffold: High-solubility matrix engineered for rapid physical disintegration. Metronidazole Tablet
FreeProduct Composition & Available Strengths
We supply Metronidazole in standard, internationally recognized strengths optimized for adult and pediatric treatment regimens.
Active Ingredient Available Strengths Common Dosage Matrix Primary Clinical Target Metronidazole BP / IP / USP 200 mg Film-Coated / Uncoated Oral Tablet Pediatric & Low-Dose Titration: For delicate adjustments in mild amoebic dysentery or combination protocols. Metronidazole BP / IP / USP 400 mg Film-Coated / Uncoated Oral Tablet Standard Generic Backbone: Standard twice or thrice-daily dosing for dental abscesses and Giardiasis. Metronidazole BP / IP / USP 500 mg High-Potency Oral Tablet Institutional Target: High-volume strength preferred for anaerobic surgical prophylaxis and severe trichomoniasis. Nicoumalone Tablet
FreeProduct Composition & Calibration Spectrum
We manufacture Nicoumalone in a complete, highly precise range of strengths to allow for the exact dosage adjustments required to maintain narrow therapeutic targets.
Active Ingredient Common Name Compendial Monograph Available Strengths Primary Clinical Application Nicoumalone (Acenocoumarol) BP / IP / USP 1 mg Micro-Titration Phase: For delicate, low-dose fine-tuning in geriatric or sensitive patient profiles. Nicoumalone (Acenocoumarol) BP / IP / USP 2 mg Foundational Maintenance: The standard baseline dose for routine daily thromboembolic prophylaxis. Nicoumalone (Acenocoumarol) BP / IP / USP 3 mg Intermediate Control: For patients requiring step-up adjustment to hit targeted coagulation thresholds. Nicoumalone (Acenocoumarol) BP / IP / USP 4 mg High-Threshold Suppression: For rapid oral loading or patients presenting high chemical resistance to standard doses. Ofloxacin Tablets
FreeOfloxacin Tablets 200 mg
Each Filmcoated tablet contains :
Ofloxacin IP 200 mg
Excipients q.sYALLEY FLOX
Ofloxacin Tablets 200mg Each Film coated tablet contains :
Ofloxacin BP 200 mg
Excipients q.sOfnis -200
Ofloxacin Tablets
Each Filmcoated tablet contains :
Ofloxacin BP 200 mgUsage: – Treat bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Oxcarbazepine Tablet
FreeProduct Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
Active Ingredient Available Strengths Primary Clinical Target Oxcarbazepine IP / BP / USP 150 mg Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. Oxcarbazepine IP / BP / USP 300 mg Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. Oxcarbazepine IP / BP / USP 600 mg High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization.
